Incyte (INCY) Other Operating Expenses (2012 - 2026)

Incyte (INCY) has 15 years of Other Operating Expenses data on file, last reported at $127.6 million in Q1 2026.

• Quarterly Other Operating Expenses rose 50.51% year-over-year to $127.6 million in Q1 2026, while the trailing twelve-month figure through Jun 2026 was $127.6 million (down 60.99% YoY) and the FY2025 annual result came in at $242.3 million, changed N/A from the prior year.
• Other Operating Expenses slipped to $127.6 million in Q1 2026, from $242.3 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $242.3 million in Q2 2025 to a low of $34.5 million in Q3 2022.
• A 5-year average of $86.1 million and a median of $68.9 million in 2023 frame the typical range for Other Operating Expenses.
• Annual changes were most pronounced in 2022 — Other Operating Expenses slumped 33.64% — and 2023, when it jumped 76.2%.
• Tracing INCY's Other Operating Expenses over 5 years: stood at $82.4 million in 2022, then rose by 13.24% to $93.3 million in 2023, then sank by 36.28% to $59.5 million in 2024, then surged by 307.32% to $242.3 million in 2025, then plunged by 47.34% to $127.6 million in 2026.
• The last three Other Operating Expenses figures came in at $127.6 million (Q1 2026), $242.3 million (Q2 2025), and $84.8 million (Q1 2025), per Business Quant data.